Locations and contributions of the phosphotransferases EPT1 and CEPT1 to the biosynthesis of ethanolamine phospholipids.

Kennedy pathway choline/ethanolamine phosphotransferase 1 ethanolamine phosphotransferase 1 phosphatidylcholine phosphatidylethanolamine phospholipid biosynthesis phospholipid metabolism plasmalogens

Journal

Journal of lipid research
ISSN: 1539-7262
Titre abrégé: J Lipid Res
Pays: United States
ID NLM: 0376606

Informations de publication

Date de publication:
08 2020
Historique:
received: 11 05 2020
revised: 17 06 2020
pubmed: 25 6 2020
medline: 14 8 2021
entrez: 25 6 2020
Statut: ppublish

Résumé

The final step of the CDP-ethanolamine pathway is catalyzed by ethanolamine phosphotransferase 1 (EPT1) and choline/EPT1 (CEPT1). These enzymes are likely involved in the transfer of ethanolamine phosphate from CDP-ethanolamine to lipid acceptors such as 1,2-diacylglycerol (DAG) for PE production and 1-alkyl-2-acyl-glycerol (AAG) for the generation of 1-alkyl-2-acyl-glycerophosphoethanolamine. Here, we investigated the intracellular location and contribution to ethanolamine phospholipid (EP) biosynthesis of EPT1 and CEPT1 in HEK293 cells. Immunohistochemical analyses revealed that EPT1 localizes to the Golgi apparatus and CEPT1 to the ER. We created EPT1-, CEPT1-, and EPTI-CEPT1-deficient cells, and labeling of these cells with radio- or deuterium-labeled ethanolamine disclosed that EPT1 is more important for the de novo biosynthesis of 1-alkenyl-2-acyl-glycerophosphoethanolamine than is CEPT1. EPT1 also contributed to the synthesis of PE species containing the fatty acids 36:1, 36:4, 38:5, 38:4, 38:3, 40:6, 40:5, and 40:4. In contrast, CEPT1 was important for PE formation from shorter fatty acids such as 32:2, 32:1, 34:2, and 34:1. Brefeldin A treatment did not significantly affect the levels of the different PE species, indicating that the subcellular localization of the two enzymes is not responsible for their substrate preferences. In vitro enzymatic analysis revealed that EPT1 prefers AAG 16-20:4 > DAG 18:0-20:4 > DAG 16:0-18:1 = AAG 16-18:1 as lipid acceptors and that CEPT1 greatly prefers DAG 16:0-18:1 to other acceptors. These results suggest that EPT1 and CEPT1 differ in organelle location and are responsible for the biosynthesis of distinct EP species.

Identifiants

pubmed: 32576654
pii: S0022-2275(20)43490-X
doi: 10.1194/jlr.RA120000898
pmc: PMC7397746
doi:

Substances chimiques

Phospholipids 0
Ethanolamine 5KV86114PT
Ethanolaminephosphotransferase EC 2.7.8.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1221-1231

Informations de copyright

Copyright © 2020 Horibata et al.

Références

J Biol Chem. 1985 Mar 10;260(5):2930-6
pubmed: 3919012
Can J Biochem Physiol. 1959 Aug;37(8):911-7
pubmed: 13671378
J Lipid Res. 2007 Mar;48(3):503-8
pubmed: 17132865
J Biol Chem. 1972 Sep 10;247(17):5442-7
pubmed: 4403444
Anal Chem. 2009 Mar 1;81(5):1920-30
pubmed: 19186979
Biochem J. 1999 Apr 15;339 ( Pt 2):291-8
pubmed: 10191259
Traffic. 2015 Jan;16(1):1-18
pubmed: 25243850
Mol Biol Cell. 2002 Sep;13(9):3148-61
pubmed: 12221122
J Am Soc Mass Spectrom. 2004 Oct;15(10):1499-508
pubmed: 15465363
J Lipid Res. 2018 Aug;59(8):1341-1366
pubmed: 29884707
Neurochem Res. 1994 Jun;19(6):769-75
pubmed: 8065535
J Lipid Res. 2010 Jun;51(6):1581-90
pubmed: 19965583
Science. 2019 Oct 4;366(6461):128-132
pubmed: 31604315
J Lipid Res. 1969 Sep;10(5):504-6
pubmed: 4309189
J Lipid Res. 2018 Jun;59(6):1015-1026
pubmed: 29500230
Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):7792-7798
pubmed: 32209662
J Biol Chem. 2007 Sep 28;282(39):28362-72
pubmed: 17673461
J Lipid Res. 1998 Oct;39(10):1907-17
pubmed: 9788237
Methods Enzymol. 1981;71 Pt C:710-25
pubmed: 6268935
Brain. 2017 Mar 1;140(3):547-554
pubmed: 28052917
J Cell Biol. 1995 Dec;131(6 Pt 2):1715-26
pubmed: 8557739
J Lipid Res. 2012 Apr;53(4):776-83
pubmed: 22266369
J Biol Chem. 1977 Jan 10;252(1):260-7
pubmed: 319093
J Lipid Res. 2018 Jun;59(6):923-944
pubmed: 29661786
Sci Rep. 2015 Nov 18;5:16787
pubmed: 26577437

Auteurs

Yasuhiro Horibata (Y)

Department of Biochemistry, Dokkyo Medical University School of Medicine, Mibu, Tochigi 321-0293, Japan.

Hiromi Ando (H)

Department of Biochemistry, Dokkyo Medical University School of Medicine, Mibu, Tochigi 321-0293, Japan.

Hiroyuki Sugimoto (H)

Department of Biochemistry, Dokkyo Medical University School of Medicine, Mibu, Tochigi 321-0293, Japan h-sugi@dokkyomed.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH